Andrew McCloskey

View Scopus Profile

ATU Donegal Letterkenny
Ash Lane, F91 YW50, Co. Sligo
Ireland

h-index

Research activity per year

6 Article
1 Review article

7 results

2024
MicroRNA regulation of islet and enteroendocrine peptides: Physiology and therapeutic implications for type 2 diabetes
Carr, E. R., Higgins, P. B., McClenaghan, N. H., Flatt, P. R. & McCloskey, A. G., Jun 2024, In: Peptides. 176, 171196.
Research output: Contribution to journal › Article › peer-review

Open Access
2023
Antidiabetic actions of GPR55 agonist Abn-CBD and sitagliptin in obese-diabetic high fat fed mice
McCloskey, A. G., Miskelly, M. G., Lafferty, R. A., Flatt, P. R. & McKillop, A. M., Feb 2023, In: Biochemical Pharmacology. 208, 115398.
Research output: Contribution to journal › Article › peer-review

Open Access
6 Citations (Scopus)
2021
Development and characterisation of novel, enzymatically stable oxytocin analogues with beneficial antidiabetic effects in high fat fed mice
Mohan, S., McCloskey, A. G., McKillop, A. M., Flatt, P. R., Irwin, N. & Moffett, R. C., Mar 2021, In: Biochimica et Biophysica Acta - General Subjects. 1865, 3, 129811.
Research output: Contribution to journal › Article › peer-review

Open Access
11 Citations (Scopus)
2020
A long-acting, dual-agonist analogue of lamprey GLP-1 shows potent insulinotropic, β-cell protective, and anorexic activities and improves glucose homeostasis in high fat-fed mice
Graham, G. V., McCloskey, A., Abdel-Wahab, Y. H., Conlon, J. M. & Flatt, P. R., 1 Jan 2020, In: Molecular and Cellular Endocrinology. 499, 110584.
Research output: Contribution to journal › Article › peer-review

Open Access
7 Citations (Scopus)
CRISPR/Cas9 gene editing demonstrates metabolic importance of GPR55 in the modulation of GIP release and pancreatic beta cell function
McCloskey, A. G., Miskelly, M. G., Moore, C. B. T., Nesbit, M. A., Christie, K. A., Owolabi, A. I., Flatt, P. R. & McKillop, A. M., Mar 2020, In: Peptides. 125, 170251.
Research output: Contribution to journal › Review article › peer-review

Open Access
19 Citations (Scopus)
Peptide YY (1–36) peptides from phylogenetically ancient fish targeting mammalian neuropeptide Y1 receptors demonstrate potent effects on pancreatic β-cell function, growth and survival
Lafferty, R. A., Tanday, N., McCloskey, A., Bompada, P., De Marinis, Y., Flatt, P. R. & Irwin, N., 1 Mar 2020, In: Diabetes, Obesity and Metabolism. 22, 3, p. 404-416 13 p.
Research output: Contribution to journal › Article › peer-review

Open Access
25 Citations (Scopus)
Pharmacological potential of novel agonists for FFAR4 on islet and enteroendocrine cell function and glucose homeostasis
McCloskey, A. G., Miskelly, M. G., Flatt, P. R. & McKillop, A. M., 15 Jan 2020, In: European Journal of Pharmaceutical Sciences. 142, 105104.
Research output: Contribution to journal › Article › peer-review

Open Access
16 Citations (Scopus)

Andrew McCloskey

Research output

Search results

MicroRNA regulation of islet and enteroendocrine peptides: Physiology and therapeutic implications for type 2 diabetes

Antidiabetic actions of GPR55 agonist Abn-CBD and sitagliptin in obese-diabetic high fat fed mice

Development and characterisation of novel, enzymatically stable oxytocin analogues with beneficial antidiabetic effects in high fat fed mice

A long-acting, dual-agonist analogue of lamprey GLP-1 shows potent insulinotropic, β-cell protective, and anorexic activities and improves glucose homeostasis in high fat-fed mice

CRISPR/Cas9 gene editing demonstrates metabolic importance of GPR55 in the modulation of GIP release and pancreatic beta cell function

Peptide YY (1–36) peptides from phylogenetically ancient fish targeting mammalian neuropeptide Y1 receptors demonstrate potent effects on pancreatic β-cell function, growth and survival

Pharmacological potential of novel agonists for FFAR4 on islet and enteroendocrine cell function and glucose homeostasis